Spruce Biosciences Files Definitive Proxy Statement
Ticker: SPRB · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1683553
| Field | Detail |
|---|---|
| Company | Spruce Biosciences, Inc. (SPRB) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, regulatory-filing
Related Tickers: SPRU
TL;DR
SPRU proxy filed: Shareholders vote on company direction.
AI Summary
Spruce Biosciences, Inc. filed its definitive proxy statement on April 28, 2025, for the fiscal year ending December 31, 2024. The filing, designated as DEF 14A, outlines information for shareholders regarding the company's annual meeting and related matters. Spruce Biosciences, Inc. is a pharmaceutical preparations company based in South San Francisco, CA.
Why It Matters
This filing provides shareholders with crucial information for upcoming decisions, including voting on company matters and electing directors, impacting the company's future direction.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the proxy statement.)
Key Players & Entities
- SPRUCE BIOSCIENCES, INC. (company) — Registrant
- 0000950170-25-059288 (filing_id) — Accession Number
- 20250428 (date) — Filing Date
- 20250609 (date) — Period of Report
- 611 Gateway Boulevard, Suite 740 (address) — Company Business Address
- South San Francisco, CA (location) — Company Location
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for their annual or special meetings. It provides detailed information about matters to be voted on, such as director elections, executive compensation, and other corporate actions.
When was this specific DEF 14A filing made by Spruce Biosciences, Inc.?
Spruce Biosciences, Inc. filed this Definitive Proxy Statement on April 28, 2025.
What is the fiscal year end for Spruce Biosciences, Inc. as indicated in this filing?
The fiscal year end for Spruce Biosciences, Inc. is December 31, as stated in the filing.
Where is Spruce Biosciences, Inc. located?
Spruce Biosciences, Inc. is located at 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080.
Is this a preliminary or definitive proxy statement?
This is a Definitive Proxy Statement, indicated by the checkbox 'Definitive Proxy Statement' being selected.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding SPRUCE BIOSCIENCES, INC. (SPRB).